Related Experiment Video
Updated: Jun 2, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial
Ali Islek1, Ayfer Gür Güven, Mustafa Koyun
1Pediatrics, Akdeniz University, 07070 Antalya, Turkey.
Insights
In infants with ureteropelvic junction obstruction (UPJO), the risk of urinary tract infection (UTI) is minimal, even with severe hydronephrosis. This study found no UTIs or kidney scarring, suggesting antibiotic prophylaxis is unnecessary for these infants.
Area of Science:
- Pediatric Urology
- Nephrology
- Infectious Disease
Background:
- Ureteropelvic junction obstruction (UPJO) is a common congenital anomaly.
- The risk of urinary tract infection (UTI) in infants with UPJO and the need for antibiotic prophylaxis remain unclear.
- Prospective studies are lacking to guide clinical practice.
Purpose of the Study:
- To assess the incidence of UTI in infants diagnosed with UPJO.
- To determine if the degree of hydronephrosis influences UTI risk.
- To evaluate the necessity of antibiotic prophylaxis in this population.
Main Methods:
- Prospective follow-up of 84 infants with UPJO (diagnosed prenatally or within 28 days of birth) without antibiotic prophylaxis.
- Standardized imaging protocols, including dimercaptosuccinate (DMSA) scintigraphy at 1-year follow-up.
- Median follow-up duration of 18 months.
Main Results:
- No cases of UTI were observed in any of the 84 infants during the median 18-month follow-up period.
- Dimercaptosuccinate (DMSA) scintigraphy revealed no pyelonephritic scarring in any participant.
- The incidence of UTI was minimal across all grades of hydronephrosis.
Conclusions:
- Antibiotic prophylaxis is not indicated for infants with ureteropelvic junction obstruction (UPJO).
- The risk of urinary tract infection (UTI) is low, irrespective of hydronephrosis severity.
- This evidence supports a conservative approach, avoiding routine antibiotic use in infants with UPJO.
Abstract:
In infants with ureteropelvic junction obstruction (UPJO), the risk of urinary tract infection (UTI) is unknown, and there is a lack of prospective studies showing definitive evidence regarding the benefits and necessity of antibiotic prophylaxis. The aim of this study was to assess the risk of UTI in infants with UPJO and to determine whether the risk varies according to the degree of hydronephrosis. Infants with hydronephrosis detected prenatally or within the postnatal 28th day and who had no previous history of UTI were followed prospectively without antibacterial prophylaxis. Imaging studies were performed according to our Pediatric Uro-Nephrology Study Group protocol. Dimercaptosuccinate (DMSA) scintigraphy was performed in all infants at the end of 1 year of follow-up. Eighty-four infants (56 boys, 28 girls) were included in the study. The distribution of patients in each hydronephrosis grading group was incidentally similar. Within a median follow-up period of 18 (12-24) months, none of the patients had UTI. Furthermore, no pyelonephritic scar was found on DMSA scans in any patient. We conclude that prophylactic antibiotic usage is not indicated in infants with UPJO, regardless of the severity of hydronephrosis, as the risk of UTI is minimal in this population.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction
Microbiota of the Urogenital Tract
Urine Studies II: Urine Culture and Sensitivity Test

